KALV earnings: a positive outcome, +10.4%

On September 14, 2018, KalVista Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.4% in the window around the event. It had already run +29.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.